BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34317569)

  • 1. Left Atrial Appendage Closure in a Patient With a Patent Foramen Ovale Septal Occluder Device.
    Kousa O; Mahfood-Haddad T; Patil SM; Agarwal H; Abuissa H
    JACC Case Rep; 2021 Mar; 3(3):508-511. PubMed ID: 34317569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety and efficacy of left atrial appendage closure combined with patent foramen ovale closure for atrial fibrillation patients with patent foramen ovale].
    Zhao ZH; Song X; Wang SH; Luo J; Wu YB; Zhu Q; Fang M; Huan Q; Zhang XG; Tian B; Gu W; Zhu LN; Hao SW; Ning ZP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):257-262. PubMed ID: 35340144
    [No Abstract]   [Full Text] [Related]  

  • 3. "One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation.
    Zhang ZH; Yao Q; Huang HY; Zhu P; Xu X; Song ZY; Li HK
    BMC Cardiovasc Disord; 2020 Oct; 20(1):444. PubMed ID: 33045999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplatzer left atrial appendage occlusion through a patent foramen ovale.
    Koermendy D; Nietlispach F; Shakir S; Gloekler S; Wenaweser P; Windecker S; Khattab AA; Meier B
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1190-6. PubMed ID: 24399612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closure of Iatrogenic Atrial Septal Defect After Placement of Left Atrial Appendage Closure Device.
    Sunder V; Sabir S; Mark G; Kaddissi G; Peters P; Ragupathi L
    JACC Case Rep; 2022 Aug; 4(16):1053-1055. PubMed ID: 36062052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and safety of left atrial appendage closure in a patient with previous foramen ovale occlusion: a case report.
    Matta M; Maltese L; Ugo F; Di Ruocco MV; Rametta F
    Eur Heart J Case Rep; 2021 Mar; 5(3):ytab113. PubMed ID: 33824939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
    Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
    Arch Cardiovasc Dis; 2019; 112(8-9):532-542. PubMed ID: 31378692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Atrial Thrombus Formation After Percutaneous Patent Foramen Ovale Closure.
    Regmi MR; Lara Garcia OE; Parajuli P; Madrid O; Hafiz AM
    JACC Case Rep; 2020 Apr; 2(4):636-640. PubMed ID: 34317310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental study of the bilateral asymmetric single-rivet occluder device for transcatheter patent foramen ovale closure with reserved interatrial septal puncture area.
    Wei Y; Su Y; Cao S; He Z; Wang R; Qin X; Feng Y; Yang C; Jiang H
    Front Cardiovasc Med; 2023; 10():1301412. PubMed ID: 38250032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transseptal puncture versus patent foramen ovale or atrial septal defect access for left atrial appendage closure.
    Kleinecke C; Fuerholz M; Buffle E; de Marchi S; Schnupp S; Brachmann J; Nietlispach F; Fankhauser M; Streit SR; Windecker S; Meier B; Gloekler S
    EuroIntervention; 2020 Jun; 16(2):e173-e180. PubMed ID: 31449043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Closure of the patent foramen ovale (PFO) in cryptogenic stroke].
    Diener HC; Knebel F
    Herz; 2019 Jun; 44(4):304-309. PubMed ID: 30941472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
    Han Y; Zhang X; Zhang F
    J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
    Suligoj NC; Rojko M; Suligoj B; Zorc M; Kar S; Noc M
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):349-354. PubMed ID: 31131978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the GORE® Septal Occluder (GSO) in challenging patent foramen ovale (PFO) anatomies.
    Geis NA; Pleger ST; Katus HA; Hardt SE
    J Interv Cardiol; 2015 Apr; 28(2):190-7. PubMed ID: 25728716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The feasibility and safety of combining atrial septal defect/patent foramen ovale and left atrial appendage closure: A systematic review and meta-analysis.
    Song Y; Xing H; Koch PD; Li X; Zhang Y
    Front Cardiovasc Med; 2022; 9():1080257. PubMed ID: 36684606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
    J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.